Alethia Candy Finley, RN, IgCN
Clinical Nurse Educator
Alethia “Candy” Finley, RN, IgCN is a Clinical Nurse Educator at Nufactor Specialty Pharmacy. Candy has over 35 years of infusion therapy, specializing in immunoglobulin therapy and a wide range of biologic, monoclonal antibody, and specialty medications. An Immunoglobulin Certified Nurse (IgCN), Candy empowers clinicians through training nurses and home health agencies on the administration of Nufactor’s therapies and providing continuing education on immune globulin and infliximab therapies. Candy also supports and educates patients and caregivers on their disease states and possible adverse events, ensuring patients feel supported throughout their treatment journey.
Candy's Recent Posts
IBD Treatment Updates: Navigating Today’s Biologic and Small-Molecule Landscape
An overview of biologic and small-molecule therapies for Crohn’s disease and ulcerative colitis, with key nursing considerations for home infusion therapy.
Sjögren’s Syndrome: What Nurses Need to Know About Treatment and Why Getting IVIG Approved Is Hard
This guide goes beyond the “dry eyes and dry mouth” basics to cover systemic symptoms, medication monitoring, infusion considerations, and the real hurdles nurses face getting IVIG approved for patients with Sjögren’s syndrome, all in one easy-to-reference resource.
Staying In-Scope During Challenging Home Infusion Visits
Practical tips to set boundaries, stay compliant, and protect your license. Home infusion therapy (HIT) puts you in patients’ living spaces as both a clinician and a guest. Without immediate backup like in hospitals, your scope of practice becomes critical for patient safety and to protect you and your license.
Tips and FAQs About Ordering and Organizing Infusion Supplies
Nufactor’s Clinical Nurse Educator shares tips for infusion nurses on ordering, tracking, and organizing supplies — including anaphylaxis kit checks — for infusion day.
Practical Strategies for Patients and Caregivers to Minimize Reactions with Subcutaneous Immune Globulin (SCIG)
Providing clear and concise information for patients receiving subcutaneous immune globulin (SCIG) therapy, is of utmost importance.
Hizentra® 20% Prefilled Syringe Administration: Best Practices and Administration Guidelines
The introduction of Hizentra® PFS for the treatment of patients with immunodeficiency and other disorders has simplified the infusion process for patients and caregivers. The more convenient method may promote compliance and contribute to better health outcomes.
